Optical device for non-invasive continuous monitoring of blood glucose level and HbA1c concentration
OwnerArun Ananth Aiyerinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerArun Ananth Aiyerinventor
Estimating the term…
A sensor device which is adapted for detecting target molecules in-vitro and in-vivo, comprises a MIR source emitting in 2 um to 10 um range for exciting the target species and a probe beam with orthogonal polarizations and split frequencies in the KHz. to MHz range. The probe beam measures the effects of specie concentration change and of its excitation. The evanescent fields of the orthogonally polarized beams in the probe beam undergo differential phase shifts when target species concentration changes in epidermis or when its refractive index changes due to photo-thermal excitation by the MIR beam. The phase shift is directly proportional to concentration change and refractive index change and are measured using a heterodyne interferometer operating at the same frequency as the split frequency. The measured phase shift can be related to specie concentration change in target volume.
A sensor device for in-vivo monitoring of a glucose concentration in interstitial fluid and of a glycated hemoglobin concentration in venous blood of a subject, the sensor device comprising:
Dependencies are inferred from the claim text.